Clinical Trial Update: Safety and Efficacy Study of Adjunctive Rosiglitazone in the Treatment of Uncomplicated Falciparum Malaria [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluating the safety and potential efficacy of adding rosiglitazone to standard treatment for uncomplicated falciparum malaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Falciparum Malaria

Drugs mentioned

• Rosiglitazone (rosiglitazone)

Snippet

Sponsor: Mahidol University | Conditions: Falciparum Malaria | Phase 1, Phase 2 | Status: COMPLETED